Literature DB >> 12627350

Hajj-associated outbreak strain of Neisseria meningitidis serogroup W135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers.

Annelies Wilder-Smith1, Kee Tai Goh, Timothy Barkham, Nicholas I Paton.   

Abstract

An outbreak of disease due to Neisseria meningitidis serogroup W135 (W135) occurred in 2000 and 2001 among pilgrims returning from the annual Islamic pilgrimage to Saudi Arabia (the Hajj) and in their contacts. For the Hajj in 2000, the attack rate of W135 disease was 25 cases per 100,000 pilgrims. After the introduction of quadrivalent meningococcal vaccine for the Hajj in 2001, no pilgrim developed W135 disease. The estimated attack rates for household contacts of returning pilgrims were 18 cases and 28 cases per 100,000 contacts for the years 2000 and 2001, respectively. On the basis of rates of transmission of W135 carriage and national epidemiological data, the risk that an unvaccinated household contact who had acquired W135 carriage would develop invasive meningococcal disease was estimated to be 1 case per 70 acquisitions. Public health policies to protect household contacts of Hajj pilgrims need to be implemented.

Entities:  

Mesh:

Year:  2003        PMID: 12627350     DOI: 10.1086/367858

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  32 in total

Review 1.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

2.  Preparing for infectious disease threats at mass gatherings: the case of the Vancouver 2010 Olympic Winter Games.

Authors:  Kamran Khan; Clark C Freifeld; Jun Wang; Sumiko R Mekaru; David Kossowsky; Amy L Sonricker; Wei Hu; Jennifer Sears; Angie Chan; John S Brownstein
Journal:  CMAJ       Date:  2010-02-24       Impact factor: 8.262

3.  Safety and immunogenicity of meningococcal ACWY CRM197-conjugate vaccine in children, adolescents and adults in Russia.

Authors:  Natalia Ilyina; Susanna Kharit; Leila Namazova-Baranova; Asmik Asatryan; Mayya Benashvili; Elmira Tkhostova; Chiranjiwi Bhusal; Ashwani Kumar Arora
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 4.  Neisseria meningitidis: biology, microbiology, and epidemiology.

Authors:  Nadine G Rouphael; David S Stephens
Journal:  Methods Mol Biol       Date:  2012

Review 5.  Meningococcal vaccines.

Authors:  Jens U Rüggeberg; Andrew J Pollard
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

6.  Acquisition of meningococcal serogroup W-135 carriage in Turkish Hajj pilgrims who had received the quadrivalent meningococcal polysaccharide vaccine.

Authors:  M Ceyhan; M Celik; E T Demir; V Gurbuz; A E Aycan; S Unal
Journal:  Clin Vaccine Immunol       Date:  2012-11-07

7.  The investigational meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate vaccine (ACWY-TT) and the seasonal influenza virus vaccine are immunogenic and well-tolerated when co-administered in adults.

Authors:  Mari Rose Aplasca-De Los Reyes; Efren Dimaano; Noel Macalalad; Ghassan Dbaibo; Veronique Bianco; Yaela Baine; Jacqueline Miller
Journal:  Hum Vaccin Immunother       Date:  2012-04-09       Impact factor: 3.452

8.  The immunogenicity and safety of an investigational meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate vaccine (ACWY-TT) compared with a licensed meningococcal tetravalent polysaccharide vaccine: a randomized, controlled non-inferiority study.

Authors:  Ghassan Dbaibo; Noel Macalalad; Mari Rose Aplasca-De Los Reyes; Efren Dimaano; Veronique Bianco; Yaela Baine; Jacqueline Miller
Journal:  Hum Vaccin Immunother       Date:  2012-04-09       Impact factor: 3.452

9.  Persistence of W135 Neisseria meningitidis carriage in returning Hajj pilgrims: risk for early and late transmission to household contacts.

Authors:  Annelies Wilder-Smith; Timothy M S Barkham; Sindhu Ravindran; Arul Earnest; Nicholas I Paton
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

10.  Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled study.

Authors:  Charissa Borja-Tabora; Cecilia Montalban; Ziad A Memish; Marie Van der Wielen; Veronique Bianco; Dominique Boutriau; Jacqueline Miller
Journal:  BMC Infect Dis       Date:  2013-03-05       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.